SEC Filing Summary: Trovagene, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on May 31, 2019, reporting events occurring on May 30, 2019. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol TROV.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior period are reported in this document. The filing solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
Management announced via press release (Exhibit 99.1) that Trovagene, Inc. will host a business update conference call on Friday, June 7, 2019, at 11:00 am Eastern time. No specific guidance, risks, or unusual items are detailed within the body of this 8-K.
Investor Verification Checklist
- Verify the correct registrant name is Trovagene, Inc., not Cardiff Oncology, Inc.
- Confirm the date and time of the upcoming business update conference call (June 7, 2019, 11:00 am ET).
- Review the attached press release (Exhibit 99.1) for specific details regarding the business update.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.